Diffuse Large B-Cell Lymphoma (DLBCL) is known to have lower expression of CD3+ and CD4+ tumor infiltrating lymphocytes (TILs) as well as lower PD-L1 expression as compared to HL (22). This evidence concerns the gene CD274 and neoplasm.